TARLOV CYST DISEASE FOUNDATION: Form 990EZ, tax year 2012

View the entire original 990 at ProPublica ↗

Organization
TARLOV CYST DISEASE FOUNDATION (EIN 20-5724680)
Tax period
2012-01-01 to 2012-12-31
Filed
2013-09-22
IRS object ID
201322659349200002
Schema version
2012v2.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2013-09-22T12:14:38-07:00Timestamp
Tax Period End Date2012-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1Robert S Blad PCBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line11832 Independence Square Ste AAddressLine1
CityDunwoodyCity
StateGAState
ZIP Code30338ZIPCode
FieldValueIRS element (for citing)
Return Type990EZReturnType
Tax Period Begin Date2012-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN205724680EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1TARLOV CYST DISEASE FOUNDATIONBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlTARLNameControl
Phone8655774945Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line1326 NORTON RDAddressLine1
CityKNOXVILLECity
StateTNState
ZIP Code37920ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameReta Honey Hiers RNCName
TitlePresidentTitle
Date Signed2013-09-22DateSigned
Authorize Third PartytrueAuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameROBERT S BLAD CPAName
PTINP00197666PTIN
Phone7705127600Phone
Self EmployedXSelfEmployed
FieldValueIRS element (for citing)
Tax Year2012TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990-EZ IRS990EZ

FieldValueIRS element (for citing)
Method Of Accounting CashXMethodOfAccountingCash
Web Sitewww.tarlovcystfoundation.orgWebSite
Organization501c3XOrganization501c3
Gross Receipts Less Than25000XGrossReceiptsLessThan25000
Gross Receipts18415GrossReceipts
Info In Schedule O Part IXInfoInScheduleOPartI
Contributions Gifts Grants Etc18415ContributionsGiftsGrantsEtc
Cost Other Basis And Sales Expenses0CostOtherBasisAndSalesExpenses
Fundraising Gross Income0FundraisingGrossIncome
Special Events Direct Expenses0SpecialEventsDirectExpenses
Cost Of Goods Sold0CostOfGoodsSold
Total Revenue18415TotalRevenue
Fees And Oth Pymt To Ind Contractors264FeesAndOthPymtToIndContractors
Other Expenses Total673OtherExpensesTotal
Total Expenses937TotalExpenses
Excess Or Deficit For Year17478ExcessOrDeficitForYear
Net Assets Or Fund Balances BOY49773NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY67251NetAssetsOrFundBalancesEOY

Cash Savings And Investments CashSavingsAndInvestments

FieldValueIRS element (for citing)
BOY49773BOY
EOY67251EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY49773BOY
EOY67251EOY

Net Assets Or Fund Balances NetAssetsOrFundBalances

FieldValueIRS element (for citing)
BOY49773BOY
EOY67251EOY
FieldValueIRS element (for citing)
Primary Exempt PurposeThe Tarlov Cyst Disease Foundation is a volunteer-based, 501(c)(3) non-profit foundation dedicated to the research, improved diagnosis and development of successful treatments and outcomes for symptomatic Tarlov cysts. The Foundation is incorporated exclusively for scientific, educational, and charitable purposes that will seek to improve the level of understanding, diagnosis and treatment of Tarlov cysts.PrimaryExemptPurpose

Program Service Accomplishment ProgramServiceAccomplishment

FieldValueIRS element (for citing)
Description Program Service Accom2012 Accomplishments of the Tarlov Cyst Disease FoundationA Research Grant, which was funded by the Foundation for Tarlov cyst research was implemented by the National Organization for Rare Disorders (NORD) and was awarded in June 2012. The Tarlov Cyst Disease Foundation is the only organization in the world that funds research for Tarlov cyst disease. The grant was awarded in June 2012 to a group of five investigators/researchers in Toronto Canada. The principal investigator is Kieran Murphy, M.D. Interventional Neuroradiologist, formerly at Johns Hopkins Baltimore MD. The four co-investigators are geneticists who are providing genetic testing for connective tissue disorders with Tarlov cyst patients and their families. The geneticists are Chantal Morel, M.D., Jordan Lerner-Ellis, PhD, Aaron Goldman, PhD, Josh Silver, MSc, CCGC. The Foundation has worked closely with the Principal Investigator, Dr. Murphy and the Research Coordinator, Abby Skanda. An informative letter from the Foundations President, explaining the research project, was sent to a data base of Tarlov cyst patients who had contacted the Foundation. A form for registration for becoming a part of the research study was provided to the Foundation by the clinical research coordinator and mailed with the letter. Sixteen Tarlov cyst patients in Ontario and their families were enrolled in the clinical research project in 2012. A no cost extension for the grant (without an increase in funding), was approved by the Foundation and NORD to extend the timeline on the research project beyond one year.A Harvard /Massachusetts General Clinical-Pathological Conference (CPC) was held, to present an autopsy case report of a Tarlov cyst patient. The Foundation was instrumental in working with the family to provide approval for the extensive autopsy of this patient, which was presented at the CPC. This later led to a request from the New England Journal of Medicine to publish a manuscript by Anne Louise Oaklander, M.D. PhD. and Donlin Long, M.D. PhD.in 2013 of the findings presented at the CPC meeting. Partnership continued with National Disease Research Interchange (NDRI).This partnership provides a bio-specimen tissue repository for Tarlov cyst tissue samples removed by neurosurgeons during Tarlov cyst surgery and shipped to NDRI for future researcher access to the tissue samples.A Tarlov cyst disease manuscript was written by researcher, Anne Louise Oaklander, M.D., PhD and Reta Honey Hiers, RNC, President of the Foundation, for submission to a medical journal for publication. This manuscript is a culmination of research/epidemiological study compilations over more than three years. The manuscript is in final editing and will hopefully be published in late 2013 or early 2014.Education/training sessions were provided to the hospital staff of Pine Creek Medical Center (PCMC), Dallas TX and the office staff of Frank Feigenbaum, M.D. Neurosurgeon by Reta H. Hiers, RNC, President of the Tarlov Cyst Disease Foundation. The sessions were provided as requested by the Administration at PCMC and Dr. Feigenbaum who had relocated to the Dallas area in 2012. Dr. Feigenbaum has treated more Tarlov cyst patients than anyone in the world, and has the worlds largest database of patient outcomes from surgery. He follows all patients for two years postoperatively with review of MRIs and patient surveys submitted at three month intervals for the two year period.The Tarlov Cyst Documentary Film planning and negotiations continued with the documentary film company, Ross-Campbell Productions, Inc. Final filming phases and funding of costs by the Foundation were included in these plans. Completion of the film is tentatively scheduled for 2014.A proposal was submitted for a Tarlov Cyst Workshop Presentation at the 4th Neuropathic Pain Congress sponsored by the International Association for the Study of Pain (IASP), by Reta H. Hiers, RNC, Foundation President, neurosurgeon Dr. Frank Feigenbaum and interventional neuroradiologist Dr. Kieran Murphy.The Foundations website at www.tarlovcystfoundation.org provided opportunities for patients, their families and physicians to learn more about the rare disease, Tarlov cysts and to participate in the research process. Website visits totaled more than one million by the end of 2012. Patient surveys totaling over 300 from 45 U.S. states and 33 countries were submitted on the website in 2012; the survey data was scientifically encoded, compiled, and provided to the Tarlov cyst researcher. Hundreds of Contact Us Submission Forms were submitted to the Foundation via the website and responded to during the year.In addition thousands of phone calls and e-mails from physicians and patients around the world and from all 50 U.S states were received. Advocacy efforts of the Foundation throughout the year assisted patients in appeals for denial of insurance coverage for Tarlov cyst treatment. These appeals were for denial of Social Security Administration Disability, and for efforts in seeking retirement earlier than anticipated, due to the life altering symptoms from the cysts. Additionally, numerous international patients were assisted in appeals for out of country approval for coverage of healthcare in the U.S., due to the lack of expertise of physicians in their home country in treating this life-altering diagnosis. Phone calls and e-mails, too numerous to count, were received by the Foundation from physicians, patients, patients family members, attorneys, insurance companies and others, with information and assistance provided to all as requested. We celebrate that the Tarlov Cyst Disease Foundation has been instrumental in replacing helplessness with hopefulness for patients who have been diagnosed with Tarlov cysts during the year. We look forward to increasing our efforts in advocacy, research, and education in the future.DescriptionProgramServiceAccom

Officer Director Trustee Key Empl OfficerDirectorTrusteeKeyEmpl (6 entries)

TitleTitleAvg Hours Per Wk Devoted To PositionAvgHoursPerWkDevotedToPositionCompensationCompensation
EILEEN MCTAGUE
Treas.-1 half5.000
Cathy Gray Carlomagno
Treas. 2nd half5.000
DEL DUTCHER
Director00
Sandy A Roof
Secretary5.000
Dona Dutcher
Vice President5.000
Reta Honey Hiers RNC
President60.000
FieldValueIRS element (for citing)
Info In Schedule O Part VXInfoInScheduleOPartV
Activities Not Previously RptfalseActivitiesNotPreviouslyRpt
Made Changes To Orgnzng Etc DocfalseMadeChangesToOrgnzngEtcDoc
Organization Had UBIfalseOrganizationHadUBI
Organization Filed990 TfalseOrganizationFiled990T
Subject To Proxy TaxfalseSubjectToProxyTax
Organization Dissolved EtcfalseOrganizationDissolvedEtc
Did Org File Form1120 POL This YearfalseDidOrgFileForm1120POLThisYear
Made Loans To From OfficersfalseMadeLoansToFromOfficers
Initiation Fees And Capital Contri0InitiationFeesAndCapitalContri
Gross Receipts For Public Use0GrossReceiptsForPublicUse
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTrans
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTrans

The Books Are In Care Of TheBooksAreInCareOf

FieldValueIRS element (for citing)
Name PersonCathy G CarlomagnoNamePerson

Address US AddressUS

FieldValueIRS element (for citing)
Address Line1326 NORTON RDAddressLine1
CityKNOXVILLECity
StateTNState
ZIP Code379206648ZIPCode
FieldValueIRS element (for citing)
Telephone Number8655774945TelephoneNumber
FieldValueIRS element (for citing)
Foreign Financial AccountfalseForeignFinancialAccount
Foreign OfficefalseForeignOffice
Maintain Any Donor Advised FundsfalseMaintainAnyDonorAdvisedFunds
Does Org Have HospitalfalseDoesOrgHaveHospital
Tanning Services ProvidedfalseTanningServicesProvided
Form720 FiledfalseForm720Filed
Related Org Controlled EntityfalseRelatedOrgControlledEntity
Transaction With Control EntityfalseTransactionWithControlEntity
Engage Political Cmpgn ActivitiesfalseEngagePoliticalCmpgnActivities
Engage In Lobbying ActivitiesfalseEngageInLobbyingActivities
Operating SchoolfalseOperatingSchool
Trnsfrs Exempt Non Char Related OrgfalseTrnsfrsExemptNonCharRelatedOrg
Related Org Section527 OrgfalseRelatedOrgSection527Org
Part VI Of Comp Of Highest Paid EmplNONEPartVIOfCompOfHighestPaidEmpl
Part VIA Hghst Paid Cntrct Prof SerNONEPartVIAHghstPaidCntrctProfSer
Filed Schedule AtrueFiledScheduleA

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Publicly Supported Org509a2XPubliclySupportedOrg509a2

Gifts Grants Contrib Received509 GiftsGrantsContribReceived509

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years23799CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years27082CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years49594CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year28036CurrentTaxYearMinus1Year
Current Tax Year18415CurrentTaxYear
Total146926Total

Gross Receipts From Admissions GrossReceiptsFromAdmissions

FieldValueIRS element (for citing)
Total0Total

Gross Receipts From Non UBI GrossReceiptsFromNonUBI

FieldValueIRS element (for citing)
Total0Total

Tax Rev Levied For Org Benefit509 TaxRevLeviedForOrgBenefit509

FieldValueIRS element (for citing)
Total0Total

Value Of Svcs Fclts Furnishd By Govt ValueOfSvcsFcltsFurnishdByGovt

FieldValueIRS element (for citing)
Total0Total

Total509 Total509

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years23799CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years27082CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years49594CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year28036CurrentTaxYearMinus1Year
Current Tax Year18415CurrentTaxYear
Total146926Total

Amts Recd From Disqual Persons AmtsRecdFromDisqualPersons

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years15000CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years20035CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years26000CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year17035CurrentTaxYearMinus1Year
Current Tax Year8000CurrentTaxYear
Total86070Total

Amts From Subst Contributors AmtsFromSubstContributors

FieldValueIRS element (for citing)
Total0Total

Support From DQ Ps Etc SupportFromDQPsEtc

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years15000CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years20035CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years26000CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year17035CurrentTaxYearMinus1Year
Current Tax Year8000CurrentTaxYear
Total86070Total
FieldValueIRS element (for citing)
Public Support Total50960856PublicSupportTotal509

Gross Investment Income509 GrossInvestmentIncome509

FieldValueIRS element (for citing)
Total0Total

Post1975 UBTI Post1975UBTI

FieldValueIRS element (for citing)
Total0Total

Net Income From Other UBI NetIncomeFromOtherUBI

FieldValueIRS element (for citing)
Total0Total

Other Income509 OtherIncome509

FieldValueIRS element (for citing)
Total0Total

Total Support Total TotalSupportTotal

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years23799CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years27082CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years49594CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year28036CurrentTaxYearMinus1Year
Current Tax Year18415CurrentTaxYear
Total146926Total
FieldValueIRS element (for citing)
Public Support Percentage5090.41420PublicSupportPercentage509
Prior Year Support Percentage0.38590PriorYearSupportPercentage
Investment Income Percentage0.00000InvestmentIncomePercentage
Thirty Three Percnt Tests CY509XThirtyThreePercntTestsCY509

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (3 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
Form 990-EZ, Part I, Line 16.3Other Expenses.3DOMAIN NAME RENEWAL $30
Form 990-EZ, Part I, Line 16.2Other Expenses.2OTHER $125
Form 990-EZ, Part I, Line 16.1Other Expenses.1WEBSITE $518

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.